INHC — Induction Healthcare Share Price
Last trade - 00:00- £7.04m
- £3.41m
- £13.65m
- 46
- 66
- 15
- 34
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.35 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.52 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -15.49% | ||
| Return on Equity | -14.53% | ||
| Operating Margin | -30.79% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 0.15 | 1.36 | 7.23 | 12.88 | 13.65 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Induction Healthcare Group PLC is a digital health platform company. The Company is engaged in the provision of software to healthcare professionals. It delivers a suite of software solutions that transforms care delivery and the patient journey through hospital. Its system applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face, giving the communities control and ease of access. Its Induction Zesty is a patient engagement platform that enables healthcare providers to offer self-directed care management. Its capabilities include registration, appointments, paperless, messaging, questionnaires, video consultation, integration, and analytics and reporting. Through its accessible Web-based patient portal, patients can easily register using its simple online registration options. Its remote healthcare interaction gives patients a way to access their clinician or care team using a video call from their own device.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- February 28th, 2019
- Public Since
- May 22nd, 2019
- No. of Employees
- 74
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- London Stock Exchange
- Shares in Issue
- 93,849,000
- Address
- c/o Pinsent Masons, LONDON, EC2A 4ES
- Web
- https://www.inductionhealthcare.com
- Phone
- Auditors
- Crowe UK LLP
Latest News for INHC
Upcoming Events for INHC
Half Year 2025 Induction Healthcare Group PLC Earnings Release
Similar to INHC
1Spatial
London Stock Exchange
4Global
London Stock Exchange
accesso Technology
London Stock Exchange
Activeops
London Stock Exchange
Acuity RM
London Stock Exchange
FAQ
As of Today at 21:18 UTC, shares in Induction Healthcare are trading at 7.50p. This share price information is delayed by 15 minutes.
Shares in Induction Healthcare last closed at 7.50p and the price had moved by -62.5% over the past 365 days. In terms of relative price strength the Induction Healthcare share price has underperformed the FTSE All Share Index by -65.24% over the past year.
The overall consensus recommendation for Induction Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreInduction Healthcare does not currently pay a dividend.
Induction Healthcare does not currently pay a dividend.
Induction Healthcare does not currently pay a dividend.
To buy shares in Induction Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 7.50p, shares in Induction Healthcare had a market capitalisation of £7.04m.
Here are the trading details for Induction Healthcare:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: INHC
Based on an overall assessment of its quality, value and momentum Induction Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Induction Healthcare is 30.00p. That is 300% above the last closing price of 7.50p.
Analysts covering Induction Healthcare currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Induction Healthcare. Over the past six months, its share price has underperformed the FTSE All Share Index by -53.64%.
As of the last closing price of 7.50p, shares in Induction Healthcare were trading -46.9% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Induction Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 7.50p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Induction Healthcare's directors